Skip to main content

stock

IRWD · IRONWOOD PHARMACEUTICALS INC

What IRONWOOD PHARMACEUTICALS INC reports to the SEC, read from its filings.

Open in the app

Price

The live IRWD price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on IRWD.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
165,239,947 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
60.1%
Net
33.4%

Returns

ROE
—
ROA
45.5%

Health

Current ratio
6.1x
Debt/equity
—

Deep value

NCAV
-$247.77M
NCAV per share
-$1.50
Price/NCAV
Locked
NNWC
-$283.30M
NNWC per share
-$1.71
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$113.04M—Gross profit: unreported by this company.$79.31M$51.29M
10-Q filed 2026-08-06
2026-03-31$106.51M—Gross profit: unreported by this company.$72.57M$40.77M
10-Q filed 2026-05-07
2025-12-31$47.71M—Gross profit: unreported by this company.$6.80M-$2.28M
10-K filed 2026-02-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$122.06M—Gross profit: unreported by this company.$75.48M$40.08M
10-K filed 2026-02-26
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30$85.24M—Gross profit: unreported by this company.$45.32M$23.60M
10-Q filed 2026-08-06
2025-03-31$41.14M—Gross profit: unreported by this company.-$29.11M-$37.39M
10-Q filed 2026-05-07
2024-12-31$90.55M—Gross profit: unreported by this company.$31.49M$2.26M
10-K filed 2026-02-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$91.59M—Gross profit: unreported by this company.$25.64M$3.65M
10-K filed 2026-02-26
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$285.13M
Equity
-$161.84M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$296.15M$98.50M$24.02M$127.01M
2024-12-31$351.41M$93.12M$880,000$103.41M
2023-12-31$442.74M-$945.43M-$1.03B$183.15M
2022-12-31$410.60M$250.34M$175.06M$273.63M
2021-12-31$413.75M$232.26M$528.45M$261.63M
2020-12-31$389.52M$142.94M$106.18M$166.99M
2019-12-31$428.41M$120.12M$21.50M$3.54M
2018-12-31$346.64M-$150.67M-$282.37M-$71.23M
2017-12-31$298.28M-$15.36M-$116.94M-$103.56M
2016-12-31$273.96M-$51.87M-$81.71M-$30.14M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

  • Silver Ronald

    PFO & PAO

    Sale$578,063

    Jul 9, 4:32 PM ET

All insider trades for IRWD

Politician trades, last 90 days

Funds

News

Stories that named IRWD, and the market events around them.

Sign in to see this

Board

The IRWD board could not be loaded.

Retry the IRWD board

nakagai

Signals on IRWD come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the IRWD board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

IRONWOOD PHARMACEUTICALS INC (IRWD): SEC filings, financials and insider trades · Nakagai